AMANDA MISSO: Open Payments
NPI 1477010668 · STARKVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,374 in 79 payments from 18 companies in 2025. Trend: 2023 $1,257 · 2024 $1,568 · 2025 $1,374
Food & beverage: $1,374
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $225 |
| AstraZeneca Pharmaceuticals LP | 9 | $193 |
| Novo Nordisk Inc | 11 | $183 |
| PFIZER INC. | 11 | $175 |
| Lilly USA, LLC | 10 | $173 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Averitas Pharma Inc. | 2 | $52 |
| Corcept Therapeutics | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: MOUNJARO, NURTEC ODT, Wegovy, AIRSUPRA, QULIPTA, CAPLYTA, FARXIGA, Kerendia.
Industry payments across MS — which companies pay providers there.
